Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The aim of this study is to summarize available knowledge about common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders. A literature search was carried out by using MEDLINE and references of selected articles. The search included articles published up to March 2008. The main genetic finding concerns the serotonin transporter gene promoter polymorphisms, the long variant of which seems to be related to a positive response to therapy in mood disorders and could also have a role in the treatment of anxiety disorders. Among other predictors, the main factors common to both classes of disorder are comorbid axis II disorders and early onset of illness, which are related to a worse response to therapy and concomitant good physical conditions, absence of earlier treatments, early administration and response to therapies, and higher self- directedness, which is related to a better outcome. Many common predictors have been identified and these seem to be related to features covering the totality of patients that go beyond specific characteristics of single disorders. Possible limitations and suggestions for future research based on a more integrated vision of human complexity are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder
(2008) · APA Practice Guidelines for the Treatment of Psychiatric Disorders: Comprehensive Guidelines and Guideline Watches · doi:10.1176/appi.books.9780890423363.149114 · Cited by 1,028 · cited 4×
“…and group therapy have been proposed for mood and anxiety disorders with results often comparable to pharmacotherapy, the only exception being BD (American Psychiatric Association, 1998, 2000, 2002; Allgulander et al., 2003; Van Ameringen et al., 2003; Ursano et al., 2004; Koran et al., 2007).”
BackgroundInfluentialRisk for recurrence in depression
Burcusa, S. L., & Iacono, W. G. (2007) · Clinical Psychology Review · doi:10.1016/j.cpr.2007.02.005 · Cited by 1,023
Residual symptoms after partial remission: an important outcome in depression
Paykel, E. S., Ramana, R., Cooper, Z., Hayhurst, H., Kerr, J., & Barocka, A. (1995) · Psychological Medicine · doi:10.1017/s0033291700033146 · Cited by 791 · cited 4×
“(2002) showed that the severity of illness could predict response in patients with primary depressive episodes in studies with both SSRI and TD (Paykel et al., 1995; Ezquiaga et al., 1998; O’Leary et al., 2000) but not in patients with recurrent depression (Kupfer and Spiker, 1981; Kocsis et al.”
BackgroundInfluentialMataix-Cols, D., Rauch, S. L., Manzo, P. A., Jenike, M. A., & Baer, L. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1409 · Cited by 716 · cited 1×
“In OCD, major severity of illness in studies with both TD and SSRI (Alarcon et al., 1993; Mataix-Cols et al., 1999; Stein et al., 2001; Shetti et al., 2005; Storch et al., 2006; Tukel et al., 2006) has always been related to a worse response.”
BackgroundPersonality disorder and the outcome of depression: Meta-analysis of published studies
Newton-Howes, G., Tyrer, P., & Johnson, T. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.188.1.13 · Cited by 537
Serretti, A., Kato, M., De Ronchi, D., & Kinoshita, T. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001926 · Cited by 529 · cited 9×
“…and that only a careful analysis of the network of their reciprocal interconnections can give a more complete view of the complexity of the possible interactions (Caspi et al., 2003; Serretti et al., 2007a, 2007b, 2007c), although this has been proven to be quite difficult (Winterer et al., 1998).”
BackgroundMethodResultInfluentialSelf-citationSouery, D., Oswald, P., Massat, I., Bailer, U., Bollen, J., Demyttenaere, K., Kasper, S., Lecrubier, Y., Montgomery, S., Serretti, A., et al. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0713 · Cited by 521 · cited 13×
“Early administration and response to therapy + (Souery et al., 2007) + + + (Gasperini et al.”
BackgroundMethodResultInfluentialSelf-citationEvidence-based pharmacotherapy of obsessive-compulsive disorder
Fineberg, N. A., Brown, A., Reghunandanan, S., & Pampaloni, I. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001829 · Cited by 336
BELZER, K., & SCHNEIER, F. R. (2004) · Journal of Psychiatric Practice · doi:10.1097/00131746-200409000-00003 · Cited by 235 · cited 2×
“This could be particularly true if we consider the large overlap between mood and anxiety disorders (Freeman et al., 2002; Belzer and Schneier, 2004) 0268-1315 c 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins DOI: 10.1097/YIC.0b013e32831db2d7 and the important role of the same…”
BackgroundInfluentialClinical Predictors of Drug Response in Obsessive-Compulsive Disorder
Erzegovesi, S., Cavallini, M. C., Cavedini, P., Diaferia, G., Locatelli, M., & Bellodi, L. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200110000-00006 · Cited by 224 · cited 3×
“…to influence the response to clomipramine in OCD (DeVeaugh-Geiss et al., 1990), to moclobemide, sertraline and clonazepam in SAD (Otto et al., 2000; Erzegovesi et al., 2001; Denys and de Geus, 2005) and in the majority of studies focusing on PD (Slaap and den Boer, 2001; Kipper et al., 2007) apart…”
BackgroundSelf-citationTrauma, resilience and saliostasis: effects of treatment in post-traumatic stress disorder
Davidson, J. R. T., Payne, V. M., Connor, K. M., Foa, E. B., Rothbaum, B. O., Hertzberg, M. A., & Weisler, R. H. (2005) · International Clinical Psychopharmacology · doi:10.1097/00004850-200501000-00009 · Cited by 216 · cited 5×
“…with a better response in a study with fluoxetine (Martenyi et al., 2002), compared with the results of two studies, one with nefazodone (Hidalgo et al., 1999) and one with tiagabine and SSRI (Davidson et al., 2005); a further study with topiramate (Berlant, 2004) found no association with sex.”
BackgroundResultInfluentialDiscontinuities and cognitive changes in an exposure-based cognitive therapy for depression
Hayes, A. M., Feldman, G. C., Beevers, C. G., Laurenceau, J.-P., Cardaciotto, L., & Lewis-Smith, J. (2007) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.75.3.409 · Cited by 198 · cited 2×
“This influence of these factors on both MD and some anxiety disorders could be explained by cognitive distortions related to the severity of illness itself and independent from the type of illness, which can create a barrier to the drug’s efficacy, in accordance with some earlier findings showing that there are cognit…”
ResultGender differences in depression and response to psychotropic medication
Gorman, J. M. (2006) · Gender Medicine · doi:10.1016/s1550-8579(06)80199-3 · Cited by 195
Anxious and non-anxious bipolar disorder
Trevor Young, L., Cooke, R. G., Robb, J. C., Levitt, A. J., & Joffe, R. T. (1993) · Journal of Affective Disorders · doi:10.1016/0165-0327(93)90118-4 · Cited by 178 · cited 1×
“…and seems to have a detrimental effect (Kleindienst et al., 2005a, 2005b); the impact of alcohol abuse, by contrast did not show any significant impact on the response to lithium (Coryell et al., 2000); and finally, no association was found with comorbid anxiety and PD in BD (Young et al., 1993).”
BackgroundOtto, M. W., Pollack, M. H., Gould, R. A., Worthington, J. J., McArdle, E. T., Rosenbaum, J. F., & Heimberg, R. G. (2000) · Journal of Anxiety Disorders · doi:10.1016/s0887-6185(00)00027-x · Cited by 175 · cited 10×
“, 1990), to moclobemide, sertraline and clonazepam in SAD (Otto et al., 2000; Erzegovesi et al., 2001; Denys and de Geus, 2005) and in the majority of studies focusing on PD (Slaap and den Boer, 2001; Kipper et al.”
BackgroundResultInfluentialMajor Depressive Disorder and Axis I Diagnostic Comorbidity
Zimmerman, M., Chelminski, I., & McDermut, W. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0303 · Cited by 158
Massion, A. O., Dyck, I. R., Shea, M. T., Phillips, K. A., Warshaw, M. G., & Keller, M. B. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.5.434 · Cited by 149 · cited 8×
“Finally, the presence of avoidant and dependent personality disorder was found to be a negative predictor of response in generalized anxiety disorder (GAD) (Massion et al., 2002).”
BackgroundResultInfluentialTondo, L., Baldessarini, R. J., & Floris, G. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.41.s184 · Cited by 132
Six Months of Treatment for Depression: Outcome and Predictors of the Course of Illness
Mulder, R. T., Joyce, P. R., Frampton, C. M. A., Luty, S. E., & Sullivan, P. F. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.95 · Cited by 127
Wolf, N. J., & Hopko, D. R. (2008) · Clinical Psychology Review · doi:10.1016/j.cpr.2007.04.004 · Cited by 116 · cited 1×
“Finally, in this study we considered only the predictors of short-term response and not the long-term response (except for lithium), recurrence and relapse responses that could differ from the short-term response (Burcusa and Iacono, 2007; Wolf and Hopko, 2008).”
BackgroundRemission onset and relapse in depression
O’Leary, D., Costello, F., Gormley, N., & Webb, M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00086-5 · Cited by 87
A score for predicting response to pharmacotherapy in obsessive???compulsive disorder
Denys, D., Burger, H., van Megen, H., de Geus, F., & Westenberg, H. (2003) · International Clinical Psychopharmacology · doi:10.1097/00004850-200311000-00002 · Cited by 68
Benzodiazepines and anxiety disorders: a review for the practicing physician
Kaplan, E. M., & DuPont, R. L. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x48401 · Cited by 55
Simon, N. M., Zalta, A. K., Worthington III, J. J., Hoge, E. A., Christian, K. M., Stevens, J. C., & Pollack, M. H. (2006) · Depression and Anxiety · doi:10.1002/da.20184 · Cited by 40 · cited 5×
“In PTSD, a single study with topiramate did not find any association (Berlant, 2004), whereas in GAD, men with a younger age of onset, and especially women with older age of onset, exhibited a poorer response on the HAM for anxiety (Simon et al., 2006), so that an interaction between the parameters age at onset and se…”
BackgroundResultInfluentialA 2-Year Follow-up of Social Phobia: Status After a Brief Medication Trial
SUTHERLAND, S. M., TUPLER, L. A., COLKET, J. T., & DAVIDSON, J. R. T. (1996) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199612000-00003 · Cited by 35
Clinical predictors of early fluoxetine treatment response in obsessive-compulsive disorder
Storch, E. A., Larson, M. J., Shapira, N. A., Ward, H. E., Murphy, T. K., Geffken, G. R., Valerio, H., & Goodman, W. K. (2006) · Depression and Anxiety · doi:10.1002/da.20197 · Cited by 34 · cited 7×
“, 2005a) – – – – – – (Alarcon et al., 1993; MataixCols et al., 1999; Stein et al., 2001; Shetti et al., 2005; Storch et al., 2006; Tukel et al., 2006) + + N – (a) N (Otto et al.”
BackgroundResultInfluentialMarchesi, C., Cantoni, A., Fontò, S., Giannelli, M. R., & Maggini, C. (2006) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2006.00772.x · Cited by 30 · cited 1×
“Marchesi et al. (2006), investigating a possible relationship between personality and PD, found that, before treatment, nonremittent patients showed higher levels of HA and lower levels of persistence, SD and cooperativeness, whereas remitted patients showed only higher levels of HA.”
Background
Cited by
Liu, R. T., Walsh, R. F. L., & Sheehan, A. E. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.03.023 · Cited by 564
Porcelli, S., Fabbri, C., & Serretti, A. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.10.003 · Cited by 331
“Also clinical-demographic variables might have an impact on antidepressant efficacy (Serretti et al., 2007a, 2009) and therefore they could constitute potential stratification factors per se or in interaction with 5-HTTLPR.”
BackgroundSelf-citationSundermann, B., Bode, J., Lueken, U., Westphal, D., Gerlach, A. L., Straube, B., Wittchen, H.-U., Ströhle, A., Wittmann, A., Konrad, C., et al. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00099 · Cited by 46
Metadata
- Authors
- Serretti, A., Chiesa, A., Calati, R., Perna, G., Bellodi, L., & De Ronchi, D.
- Venue
- International Clinical Psychopharmacology
- Published
- 2009-01
- Volume
- 24
- Issue
- 1
- Pages
- 1-18
- ISSN
- 0268-1315 (ISSN-L)
- OpenAlex
- W2054479977
- Cited by
- 48
- References
- 27
- FWCI
- 2.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.